EDGAR Filing Documents for 0001104659-23-066685

Form POS AM - Post-Effective amendments for registration statement:

SEC Accession No. 0001104659-23-066685

Filing Date

2023-05-31

Accepted

2023-05-31 17:07:25

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	POS AM	tm2316413d1_posam.htm	POS AM	554751
2	EXHIBIT 23.1	tm2316413d1_ex23-1.htm	EX-23.1	2966
3	GRAPHIC	tm2316413d1_posamimg001.jpg	GRAPHIC	11715
	Complete submission text file	0001104659-23-066685.txt		575186

Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018

Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702

Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: POS AM | Act: 33 | File No.: 333-267840 | Film No.: 23981935
SIC: 2834 Pharmaceutical Preparations